Watch INBX. Know when insiders buy.
One email the day a filing lands. Free.
INBX
Inhibrx Biosciences, Inc.
93.38
−3.72 −3.83%
USD · close Oct 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
72
PASS · insiders 100, shorts 44
Insiders, 90 days
+$6.1M
net buying · 20 buys, 5 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E —DIV YIELD —FCF YIELD -9.60%REV TTM —NET INCOME −$138.2MNET DEBT $42.9M52W 57.29 – 141.84NEXT EARNINGS Nov 13SEC XBRL · TTM TO Invalid Date
Insider trading
+$6.1M
Net, 90 days
20 / 5
Buys / sells, 90 days
3
Distinct buyers · cluster
$6.3M
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 100 | $85.76 | $9K |
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 2,451 | $85.00 | $208K |
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 2,449 | $84.07 | $206K |
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 100 | $85.76 | $9K |
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 2,470 | $85.00 | $210K |
| Oct 14 | Oct 14 | Lappe Mark · Chief Executive Officer | Buy | 2,470 | $84.07 | $208K |
| Sep 28 | Sep 28 | Lappe Mark · Chief Executive Officer | Buy | 3,000 | $101.70 | $305K |
| Sep 28 | Sep 28 | Lappe Mark · Chief Executive Officer | Buy | 1,500 | $98.88 | $148K |
| Sep 25 | Sep 28 | Lappe Mark · Chief Executive Officer | Buy | 2,176 | $99.60 | $217K |
| Sep 25 | Sep 28 | Lappe Mark · Chief Executive Officer | Buy | 3,324 | $98.87 | $329K |
| Sep 23 | Sep 23 | Kayyem Jon Faiz · Director | Buy | 5,000 | $100.00 | $500K |
| Sep 16 | Sep 17 | Kayyem Jon Faiz · Director | Buy | 5,000 | $100.00 | $500K |
| Sep 15 | Sep 15 | MANHARD KIMBERLY · Director | Sell | 500 | $105.05 | $53K |
| Sep 14 | Sep 15 | MANHARD KIMBERLY · Director | Sell | 500 | $110.26 | $55K |
| Sep 11 | Sep 15 | MANHARD KIMBERLY · Director | Sell | 500 | $111.78 | $56K |
| Sep 9 | Sep 10 | MANHARD KIMBERLY · Director | Sell | 500 | $115.80 | $58K |
| Sep 8 | Sep 10 | MANHARD KIMBERLY · Director | Sell | 500 | $115.14 | $58K |
| Sep 8 | Sep 8 | Kayyem Jon Faiz · Director | Buy | 5,000 | $113.52 | $568K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 9,681 | $112.28 | $1.1M |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 1,219 | $111.88 | $136K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 500 | $108.23 | $54K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 1,100 | $107.12 | $118K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 6,605 | $100.64 | $665K |
| Sep 8 | Sep 8 | Lappe Mark · Chief Executive Officer | Buy | 5,895 | $99.29 | $585K |
| Sep 8 | Sep 8 | FORSYTH DOUGLAS · Director | Buy | 2,500 | $114.65 | $287K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.